What drugs does INDICUS PHARMA make?

INDICUS PHARMA has 4 FDA-approved drugs.

What therapeutic areas does INDICUS PHARMA focus on?

INDICUS PHARMA focuses primarily on Cardiovascular and Neurology and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

INDICUS PHARMA

CardiovascularNeurologyOphthalmology

Generics

INDICUS PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.

2008

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ACETAZOLAMIDE 2026-01-12

Labeling

ACETAZOLAMIDE 2026-01-08

Labeling

ACETAZOLAMIDE 2026-01-08

Labeling

ACETAZOLAMIDE 2026-01-08

Labeling

ACETAZOLAMIDE 2025-11-25

Manufacturing (CMC)

METFORMIN HYDROCHLORIDE 2025-11-10

ACETAZOLAMIDE 2025-09-16

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%

1 drugs

Neurology 33%

1 drugs

Ophthalmology 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Novartis big-pharma

Cardiovascular, Ophthalmology

UPJOHN big-pharma

Neurology, Cardiovascular, Ophthalmology

Baxter specialty

Cardiovascular, Ophthalmology

AbbVie big-pharma

Neurology, Ophthalmology

Bayer big-pharma

Cardiovascular, Ophthalmology

INDICUS PHARMA

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (4)

Active (1)

Discontinued (3)

Company Info